The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 14.50 (4.97%)
Spread: 0.50 (0.162%)
Open: 298.00
High: 308.00
Low: 285.50
Prev. Close: 291.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

16 May 2013 07:00

RNS Number : 8356E
Synthomer PLC
16 May 2013
 



16th May 2013

 

 

Synthomer plc

 

AGM and Interim Management Statement

 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 January to 16 May 2013.

 

Trading

 

After the Group's solid start to the year, demand in Europe was weaker than anticipated during March and April. While trading in Asia has been ahead of expectations in the year-to-date, volumes and profits for the Group overall were lower against a strong performance in the same period in 2012.

 

Since Synthomer's last update in March, the macro-economic environment in Europe has remained challenging and this has continued to impact demand. Our Europe and North America (ENA) business experienced 7% year-on-year volume declines in March and April. Weakness continued to be most evident in construction and related areas, in part due to the adverse weather conditions.

 

In Asia and Rest of the World, trading has been ahead of our expectations and demand across all business areas remains strong. Nitrile has outperformed our expectations and we now expect full year nitrile operating profit to be ahead of 2012. Our non-nitrile businesses have continued to trade well, with the benefits of strong demand restricted only by the capacity constraints we currently face in Asia.

 

The Group's additional 70,000 tonnes of nitrile capacity, completed at the end of 2012, is now operational, and our plans to bring SBR latex capability on stream in Malaysia during the second half of the year remain on track.

 

The Group's financial position remains robust, with net debt slightly higher over the first 4 months reflecting the higher levels of capital expenditure anticipated for the year, and the normal seasonal working capital outflow.

 

Outlook

 

Continued weakness in the macro-economic environment in Europe has resulted in challenging trading conditions for our business and, given the performance of our ENA business in March and April, we remain cautious about the outlook for the year. We are encouraged by the progress being made in our Asian business, with demand growth remaining strong and improved nitrile market dynamics. The Board expects this relative strength in Asia will partially offset the weakness being seen in Europe.

 

Synthomer will announce its Interim Results on Tuesday 13th August 2013.

 

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

The company will host a conference call for analysts at 8.00am (BST) today:

 

  Dial-In: +44 203 426 2886

Please quote "Synthomer" to gain access to the call

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUVVKROUAVAAR
Date   Source Headline
8th Mar 20184:39 pmRNSDirector/PDMR Shareholding
8th Mar 20184:37 pmRNSDirector/PDMR Shareholding
5th Mar 20182:43 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSResults for the year ended 31 December 2017
12th Feb 201810:27 amRNSDirector Declaration
1st Feb 20187:00 amRNSCompletion of the acquisition of BASF Pischelsdorf
2nd Jan 20187:00 amRNSDisposal of Synthomer Leuna Gmbh facility
13th Dec 20172:55 pmRNSDirector Declaration
4th Dec 20175:31 pmRNSHolding(s) in Company
27th Nov 20179:29 amRNSHolding(s) in Company
10th Nov 20179:40 amRNSDirectorate Change
9th Nov 201710:03 amRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSQ3 Trading update
9th Oct 20179:23 amRNSDirector Declaration
28th Sep 20177:00 amRNSAcquisition of BASF Pischelsdorf
18th Sep 20172:00 pmRNSHolding(s) in Company
17th Aug 201712:54 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSInterim Results for the 6 months ended 30 Jun 2017
1st Aug 20173:57 pmRNSHolding(s) in Company
10th Jul 201710:33 amRNSDirector/PDMR Shareholding
9th Jun 20173:14 pmRNSDirector/PDMR Shareholding
8th May 201712:40 pmRNSDirector/PDMR Shareholding
8th May 201712:24 pmRNSDirector/PDMR Shareholding
27th Apr 20174:05 pmRNSDirector Declaration
27th Apr 20172:53 pmRNSResult of AGM
27th Apr 20177:00 amRNSQ1 Trading update
27th Mar 20179:54 amRNSAnnual Financial Report
6th Mar 20177:02 amRNSAcquisition of Perstorp Belgium
6th Mar 20177:00 amRNSFinal Results
23rd Feb 20174:31 pmRNSAmendment TR-1 notification
8th Feb 20174:13 pmRNSHolding(s) in Company
6th Feb 201711:48 amRNSHolding(s) in Company
20th Jan 20177:00 amRNSQ4 and FY trading update
13th Dec 201610:57 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSCapital Markets Day
28th Nov 20169:51 amRNSHolding(s) in Company
18th Nov 20164:56 pmRNSHolding(s) in Company
16th Nov 201610:15 amRNSHolding(s) in Company
10th Nov 20162:23 pmRNSHolding(s) in Company
9th Nov 20164:18 pmRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSQ3 Trading update
3rd Oct 20162:11 pmRNSHolding(s) in Company
26th Sep 20169:25 amRNSHolding(s) in Company
14th Sep 20163:10 pmRNSHolding(s) in Company
14th Sep 20163:01 pmRNSHolding(s) in Company
11th Aug 20161:15 pmRNSDisposal
9th Aug 20167:00 amRNSInterim Results for six months ended 30 June 2016
7th Jul 201611:50 amRNSHolding(s) in Company
7th Jul 201610:28 amRNSDirector/PDMR Shareholding
5th Jul 201611:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.